Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

This Company and CEO are terrible. First of all they went off tangent and added so much fluff into the pipeline that wasn't necessary. Especially, when they didn't have enough cash to handle it all. Then now they are pushing aside scarring of skin and opthamology to attempt to partner out and focus on oncology. They wasted all that money on those assets now they are pushing them aside and starting on immune therapy. The problem? The problem is that these candidates are not even in the clinic yet. So I see more dilution and reverse splits on the way.

If I were the CEO I would have partnered out the scar program a long time ago. Like 2 to 3 years ago. Even if they didn't get that favorable of a deal say low-single digit to low double-digit royalty on sales at least the CEO would have boosted the share price and rewarded shareholders. The way he has handles this company is piss poor management. Don't even get me started on the IR person Tamara who is a total amateur at putting out PR's. No directors or insiders buying any shares. If directors or insiders don't have any confidence in the business why would the investing public? I would just avoid this company at all costs.